title: Treatment of growing teratoma syndrome.
authors.forename: David J
authors.initials: DJ
authors.lastname: Vaughn
authors.forename: Keith
authors.initials: K
authors.lastname: Flaherty
authors.forename: Priti
authors.initials: P
authors.lastname: Lal
authors.forename: Maryann
authors.initials: M
authors.lastname: Gallagher
authors.forename: Peter
authors.initials: P
authors.lastname: O'Dwyer
authors.forename: Keith
authors.initials: K
authors.lastname: Wilner
authors.forename: Isan
authors.initials: I
authors.lastname: Chen
authors.forename: Gary
authors.initials: G
authors.lastname: Schwartz
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors*; D018450:Disease Progression; D006801:Humans; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy* / Q000473:pathology; D016609:Neoplasms, Second Primary / Q000188:drug therapy* / Q000378:metabolism; D010879:Piperazines / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D016160:Retinoblastoma Protein / Q000378:metabolism; D013724:Teratoma / Q000188:drug therapy* / Q000378:metabolism; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; D010879:Piperazines; D011725:Pyridines; D016160:Retinoblastoma Protein; D018844:Cyclin-Dependent Kinases; C500026:palbociclib